Colon Adenocarcinoma — Trials

Colon Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 15
Ph III recruiting: 2
Growth YoY: —
Industry share: 11%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–18 of 18 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03365882	S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery	completed	Phase 2	240	SWOG Cancer Research NetworkNETWORK	2	Feb 10, 2026	clinicaltrials
NCT04109924	TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study	completed	Phase 2	42	Roswell Park Cancer InstituteOTHER	1